APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

281 hedge funds and large institutions have $7B invested in Apellis Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 79 increasing their positions, 108 reducing their positions, and 33 closing their positions.

Holders
281
Holders Change
+27
Holders Change %
+10.63%
% of All Funds
4.12%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.13%
New
64
Increased
79
Reduced
108
Closed
33
Calls
$379M
Puts
$133M
Net Calls
+$247M
Net Calls Change
+$11.8M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$371M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$984M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$128M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$147M
5
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$80.5M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$37.4M
2
SPC
2
Slate Path Capital
New York
$0
3
ITP
3
Iron Triangle Partners
Connecticut
$0
4
Macquarie Group
4
Macquarie Group
Australia
$34.9M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$984M 16,445,290 +1,278,246 +8%
EC
2
EcoR1 Capital
California
$669M 11,173,068 +273,209 +3%
ACA
3
Avoro Capital Advisors
New York
$665M 11,111,111 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$572M 9,555,678 +85,701 +0.9%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$377M 6,303,584 -215,887 -3%
Morgan Stanley
6
Morgan Stanley
New York
$371M 6,194,282 +4,585,286 +285%
BlackRock
7
BlackRock
New York
$322M 5,381,253 +108,507 +2%
Jennison Associates
8
Jennison Associates
New York
$196M 3,275,922 -266,287 -8%
State Street
9
State Street
Massachusetts
$175M 2,915,422 -322,692 -10%
OCA
10
Octagon Capital Advisors
New York
$168M 2,806,980 -323,020 -10%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$154M 2,574,133 +356,386 +16%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$147M 2,460,339 +677,098 +38%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$128M 2,145,004 +1,121,497 +110%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$125M 2,092,464 -167,302 -7%
BC
15
Boxer Capital
California
$103M 1,726,000 – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$97.6M 1,630,642 +75,816 +5%
AG
17
Artal Group
Luxembourg
$85.1M 1,421,346 -243,226 -15%
Pictet Asset Management
18
Pictet Asset Management
Switzerland
$80.5M 1,344,563 +610,413 +83%
PCH
19
Polar Capital Holdings
United Kingdom
$63.1M 1,053,440 -435 -0%
LGM
20
Logos Global Management
California
$56.9M 950,000 +200,000 +27%
Norges Bank
21
Norges Bank
Norway
$56.6M 946,213 -105,980 -10%
O
22
OrbiMed
New York
$55.2M 922,200 -338,300 -27%
Fiera Capital (Canada)
23
Fiera Capital (Canada)
Quebec, Canada
$55M 919,090 -600 -0.1%
Charles Schwab
24
Charles Schwab
California
$54.1M 904,409 +25,052 +3%
FLSM
25
Frazier Life Sciences Management
California
$53M 885,165 +271,122 +44%
1
2 3 4 5